1333113-32-8

Basic information

• Product Name: C₂₄H₃₂O₇
• CAS NO: 1333113-32-8
• Molecular Weight: 432.514
• Mol File: 1333113-32-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₄H₃₂O₇(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₄H₃₂O₇(1333113-32-8)
• EPA Substance Registry System: C₂₄H₃₂O₇(1333113-32-8)

Safety Data

• Hazardous Substances Data: 1333113-32-8(Hazardous Substances Data)

Upstream product

• 90-80-2 D-Glucono-1,5-lactone 
• 32469-28-6 (3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one 
• 30951-66-7 2-(3-bromophenyl)-2-propanol 
• 585-76-2 m-bromobenzoic acid 
• 24398-88-7 ethyl 3-bromobenzoate 
• 1333113-25-9 C₁₇H₁₉BrO 
• 67-56-1 methanol 

Downstream Products

• 1333113-36-2 C₂₃H₃₀O₆ 
• 1333113-44-2 C₃₁H₃₈O₁₀ 
• 1318793-82-6 C₂₃H₃₀O₆ 

Relevant articles and documents

Design, synthesis and in vivo anti-hyperglycemic activity of gem-dimethyl-bearing C-glucosides as SGLT2 inhibitors

A series of gem-dimethyl-bearing C-glucosides were designed and synthesized as SGLT2 inhibitors, with anhydrous aluminum chloride-mediated Friedel-Crafts alkylation to construct the gem-dimethyl functionality being the key step. The in vivo anti-hyperglycemic activity was evaluated with mice oral glucose tolerance test (OGTT), and all the synthesized compounds showed significant but less potent anti-hyperglycemic activity than the positive control dapagliflozin.